SALONPAS
A Hisamitsu Pharmaceutical topical pain-relief brand known for medicated patches, gels, creams, and related products for temporary relief of muscle and joint aches.
Last updated October 14, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
SALONPAS is a Japanese topical analgesic brand owned and marketed by Hisamitsu Pharmaceutical Co., Inc. Its principal products are medicated patches designed to deliver pain-relieving ingredients through the skin for temporary relief of minor aches and pains affecting muscles and joints. Depending on the market and product, the range may also include gels, creams, sprays, roll-ons, and other topical formats. The brand originated in Japan and is associated with Hisamitsu’s long-standing specialization in transdermal and topical medicines. Hisamitsu identifies 1934 as the year in which SALONPAS was introduced. The brand name has subsequently been used across a portfolio whose formulations, indications, active ingredients, package designs, and regulatory classifications vary by country. Products sold in the United States, Japan, and Asian markets are therefore not necessarily interchangeable, and consumers are directed to the labeling approved in their market. SALONPAS products commonly target temporary relief of minor pain associated with overexertion, strains, sprains, bruises, arthritis, and other everyday muscle or joint discomfort, subject to the claims and directions of each specific product. Many patches use nonprescription topical analgesic ingredients such as methyl salicylate, menthol, camphor, or other actives; some formulations and product lines use different ingredients or combinations. The brand’s core consumer proposition is localized, convenient, nonoral pain relief that can be applied directly to the affected area. The United States has become one of SALONPAS’s most visible international markets, where the brand is sold through pharmacies, mass retailers, grocery channels, and e-commerce. It is also established in Japan and a number of Asian markets. The product portfolio includes standard patches, larger or stronger variants, cooling or warming products, and topical non-patch formats, although availability differs by jurisdiction. SALONPAS has consequently developed a broad identity spanning everyday self-care, sports-related soreness, and age-related muscle and joint discomfort rather than a single standardized global product. As a brand, SALONPAS remains part of Hisamitsu Pharmaceutical rather than an independent company. Hisamitsu’s corporate portfolio also includes other pharmaceutical products, while SALONPAS functions as an international consumer-facing pain-relief franchise. Its long operating history, patch-centered format, and distribution across multiple countries have made it one of the company’s best-known brands. Public information does not establish a separately reported SALONPAS revenue figure, standalone stock listing, or independent corporate management team.
History
SALONPAS was introduced in Japan in 1934 by Hisamitsu Pharmaceutical, whose business developed around pharmaceutical products applied to or delivered through the skin. The brand’s early identity was built around medicated adhesive preparations intended to provide localized relief for aches and pains. Over time, SALONPAS became closely associated with the modern pain-relief patch, a format that allowed an analgesic preparation to remain in contact with a selected area for an extended period. Hisamitsu expanded the brand beyond its original domestic setting as the company developed international operations and registrations. SALONPAS products entered markets in Asia and later achieved substantial visibility in North America, particularly the United States. Internationalization required market-specific formulations, package labeling, claims, and regulatory treatment. As a result, the SALONPAS name refers to a family of related products rather than one globally identical medicine. The portfolio broadened from conventional patches into variants designed around different consumer preferences and use cases. Depending on the country, products have included larger patches, stronger or alternative formulations, warming products, cooling products, gels, creams, sprays, and other topical applications. Active ingredients and permitted indications differ by product and jurisdiction. The common commercial theme is temporary relief of minor muscle and joint pain, including discomfort associated with strains, sprains, bruises, overuse, and arthritis where the local label permits such claims. In the United States, the brand has been promoted and distributed as an over-the-counter topical pain reliever through retail and online channels. Its market presence has benefited from the familiar patch format, portability, and the appeal of applying treatment directly to the affected area rather than taking an oral medicine. In Japan and other Asian markets, SALONPAS is likewise part of the consumer self-care and topical-pharmaceutical landscape, with local product variants and distribution arrangements. SALONPAS remains a brand of Hisamitsu Pharmaceutical Co., Inc., not a separately incorporated or separately listed business. Hisamitsu’s broader corporate history includes pharmaceutical research, manufacturing, and sales activities, while SALONPAS serves as a major consumer brand within its topical and transdermal medicine portfolio. The brand continues to operate internationally, but public sources do not provide a complete, unified global chronology of every product launch, market entry, formulation change, or advertising campaign. Nor do they establish a standalone SALONPAS financial statement or a distinct executive leadership structure.
- 1934
SALONPAS introduced in Japan
[3]Hisamitsu Pharmaceutical identifies 1934 as the introduction year of the SALONPAS brand, launched as a medicated external-use pain-relief product in Japan.
International market development
[2]SALONPAS expanded beyond Japan into international markets, including the United States and multiple Asian countries, developing market-specific topical analgesic products and registrations. The timing of individual country launches is not consistently documented in the available public sources.
International expansion
The brand expanded beyond Japan and developed market-specific topical analgesic products and registrations across Asia, North America, and other regions.
Expansion into multiple topical formats
SALONPAS broadened from traditional medicated patches into larger and flexible patches, warming products, gels, creams, sprays, and other topical formats.
Products and positioning
An accessible, nonprescription topical pain-relief brand centered on convenient medicated patches for temporary relief of everyday muscle and joint aches.
Medicated pain-relief patch · 1934
SALONPAS Pain Relieving Patch
The core SALONPAS format is a medicated adhesive patch applied to an affected area for temporary relief of minor muscle and joint aches and pains. Exact active ingredients, patch dimensions, directions, warnings, and approved claims vary by market and by product version. The patch format is positioned around localized, convenient application and is commonly sold for everyday soreness, strains, sprains, bruises, and related discomfort where permitted by local labeling. Depending on the market, formulations may contain ingredients such as methyl salicylate, menthol, and camphor. Sizes, labeling, wear time, and active ingredients vary by jurisdiction.
Warming topical analgesic patch
SALONPAS-HOT
SALONPAS-HOT is a heat-oriented variant in markets where it is sold. It combines the brand’s patch-based delivery format with a warming sensation intended to complement temporary relief of minor aches and pains. Product availability, ingredients, duration of use, and labeling are market-specific, so the name should not be treated as a single globally uniform formulation. A warming version of the medicated patch concept, designed to combine topical analgesic action with a heat sensation. It is intended for localized muscular or joint discomfort and is sold in selected markets with market-specific instructions and warnings.
Topical analgesic gel
SALONPAS Gel
SALONPAS Gel extends the brand into a non-patch topical format. It is designed for direct application to areas of minor muscle or joint discomfort and may be useful to consumers who prefer a rub-on product. The active ingredients and permitted indications depend on the national formulation and regulatory label. A rub-on topical format for consumers who prefer a gel instead of an adhesive patch. It is used on localized areas of minor muscle and joint discomfort, with active ingredients and permitted claims varying by market.
Topical analgesic cream
Salonpas Cream and Spray
SALONPAS Cream is a topical formulation intended for localized application in markets where the product is available. It broadens the franchise beyond adhesive patches while retaining the brand’s focus on temporary relief of minor aches and pains. Directions, contraindications, active ingredients, and marketing claims are determined by the applicable local label. Cream and spray formats extend the Salonpas brand beyond patches and gels. They provide alternatives for application over larger or harder-to-cover areas and are distributed selectively according to local product registrations.
Medicated analgesic patch
Salonpas Pain Relief Patch
The best-known Salonpas product family consists of adhesive patches intended for temporary relief of minor aches and pains in muscles and joints. Depending on the market, formulations may contain ingredients such as methyl salicylate, menthol, and camphor. Sizes, labeling, wear time, and active ingredients vary by jurisdiction.
Topical non-steroidal anti-inflammatory product
Salonpas Arthritis Pain
A market-specific Salonpas line for arthritis-related pain relief. Products in this range use a topical anti-inflammatory active ingredient where approved and are marketed for localized joint pain. Availability and formulation depend on national regulatory authorization.
Recent events
NorthStar Sales Alliance wins MMCAP Infuse contract for two OTC products[5]
Reported:
NorthStar Sales Alliance announced a contract award with MMCAP Infuse introducing Mylanta antacid and Salonpas pain-relief patches in unit-dose, bar-coded packaging for government healthcare facilities.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/salonpas · Editorial policy · How profiles are compiled